Ophthalmic generic drug approval process: Implications for efficacy and safety

Research output: Contribution to journalArticle

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)344-349
Number of pages6
JournalJournal of Glaucoma
Volume6
Issue number5
DOIs
StatePublished - Oct 1997

Fingerprint

Drug Legislation
Generic Drugs
Drug Approval
Ophthalmic Solutions
Public Policy
Safety

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ophthalmic generic drug approval process : Implications for efficacy and safety. / Cantor, Louis.

In: Journal of Glaucoma, Vol. 6, No. 5, 10.1997, p. 344-349.

Research output: Contribution to journalArticle

@article{050d07c4a06c4a41bbf956505f73834b,
title = "Ophthalmic generic drug approval process: Implications for efficacy and safety",
author = "Louis Cantor",
year = "1997",
month = "10",
doi = "10.1097/00061198-199710000-00011",
language = "English",
volume = "6",
pages = "344--349",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Ophthalmic generic drug approval process

T2 - Implications for efficacy and safety

AU - Cantor, Louis

PY - 1997/10

Y1 - 1997/10

UR - http://www.scopus.com/inward/record.url?scp=0031446922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031446922&partnerID=8YFLogxK

U2 - 10.1097/00061198-199710000-00011

DO - 10.1097/00061198-199710000-00011

M3 - Article

C2 - 9327353

AN - SCOPUS:0031446922

VL - 6

SP - 344

EP - 349

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 5

ER -